Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Alemtuzumab (Campath IH) in Conditioning Therapy with Cyclophosphamide and Total Body Irradiation in Matched and Mismatched Unrelated Donor Transplantation of Children with Acute Lymphoblastic Leukaemia: A Report from 3 U.K. Centres.

Maged I. Gharib, MD MRCP MRCPath, Hayley M. Greenfield, MRCP MRCPath, Robert F. Wynn, MRCP, Paul Veys, MRCP, Paru Naik, Andrew M. Will, MRCP, Jacqueline M. Cornish, MRCP, Anthony Oakhill, MRCP, Nicholas J. Goulden, MRCP

Blood (2004) 104 (11): 2157.

https://doi.org/10.1182/blood.V104.11.2157.2157

Published: 2004

Journal Articles

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Russell J. Garland, PhD, Paraskevi Diamanti, PhD, Samantha E. West, PhD, Ann Green, MSc, David Carrington, PhD, Sarah J. Groves, BSc, Kerri L. Winship, BSc, Stephen P. Robinson, MD, Anthony Oakhill, MD, Jacqueline M. Cornish, MD, Derwood H. Pamphilon, MD, David I. Marks, MD, Nicholas J. Goulden, MD, Allison G. Blair, PhD, Colin G. Steward, MD

Blood (2004) 104 (11): 2244.

https://doi.org/10.1182/blood.V104.11.2244.2244

Published: 2004

Journal Articles

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia.

John Moppett, MD PhD, Jerry Hancock, PhD, Christopher J.C. Knechtli, MD PhD, Anthony Oakhill, MD, Nicholas J. Goulden, MD PhD

Blood (2004) 104 (11): 5169.

https://doi.org/10.1182/blood.V104.11.5169.5169

Published: 2004

Journal Articles

Characterization of acute lymphoblastic leukemia progenitor cells

Charlotte V. Cox, Roger S. Evely, Anthony Oakhill, Derwood H. Pamphilon, Nicholas J. Goulden, Allison Blair

Blood (2004) 104 (9): 2919–2925.

https://doi.org/10.1182/blood-2004-03-0901

Published: 2004

Journal Articles

Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure

Brigitta Versluys, Rajat Bhattacharaya, Colin Steward, Jackie Cornish, Anthony Oakhill, Nick Goulden

Blood (2004) 103 (5): 1968.

https://doi.org/10.1182/blood-2003-10-3612

Published: 2004

Journal Articles

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Ann Green, Emer Clarke, Linda Hunt, Andrew Canterbury, Alan Lankester, Geoff Hale, Herman Waldmann, Sally Goodman, Jacqueline M. Cornish, David I. Marks, Colin G. Steward, Anthony Oakhill, Derwood H. Pamphilon

Blood (1999) 94 (7): 2236–2246.

https://doi.org/10.1182/blood.V94.7.2236.419k04_2236_2246

Published: 1999

Journal Articles

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Christopher J.C. Knechtli, Nicholas J. Goulden, Jeremy P. Hancock, Victoria L.G. Grandage, Emma L. Harris, Russell J. Garland, Claire G. Jones, Anthony W. Rowbottom, Linda P. Hunt, Ann F. Green, Emer Clarke, Alan W. Lankester, Jacqueline M. Cornish, Derwood H. Pamphilon, Colin G. Steward, Anthony Oakhill

Blood (1998) 92 (11): 4072–4079.

https://doi.org/10.1182/blood.V92.11.4072

Published: 1998

NARROW

Alemtuzumab (Campath IH) in Conditioning Therapy with Cyclophosphamide and Total Body Irradiation in Matched and Mismatched Unrelated Donor Transplantation of Children with Acute Lymphoblastic Leukaemia: A Report from 3 U.K. Centres.

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia.

Characterization of acute lymphoblastic leukemia progenitor cells

Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Alemtuzumab (Campath IH) in Conditioning Therapy with Cyclophosphamide and Total Body Irradiation in Matched and Mismatched Unrelated Donor Transplantation of Children with Acute Lymphoblastic Leukaemia: A Report from 3 U.K. Centres.

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia.

Characterization of acute lymphoblastic leukemia progenitor cells

Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only